Literature DB >> 21984270

Susceptibility of Pseudomonas aeruginosa urinary tract isolates and influence of urinary tract conditions on antibiotic tolerance.

Maike Narten1, Nathalie Rosin, Max Schobert, Petra Tielen.   

Abstract

Pseudomonas aeruginosa is an opportunistic human pathogen, which can cause severe urinary tract infections (UTIs). Because of the high intrinsic antibiotic resistance of P. aeruginosa and its ability to develop new resistances during antibiotic treatment, these infections are difficult to eradicate. The antibiotic susceptibility of 32 P. aeruginosa isolates from acute and chronic UTIs were analysed under standardized conditions showing 19% multi-drug resistant strains. Furthermore, the antibiotic tolerance of two P. aeruginosa strains to ciprofloxacin and tobramycin was analysed under urinary tract-relevant conditions which considered nutrient composition, biofilm growth, growth phase, and oxygen concentration. These conditions significantly enhance the antibiotic tolerance of P. aeruginosa up to 6000-fold indicating an adaptation of the bacterium to the specific conditions present in the urinary tract. This reversible phenomenon is possibly due to the increased formation of persister cells and is based on iron limitation in artificial urine. The results suggest that the general high antibiotic resistance of P. aeruginosa urinary tract isolates together with the increasing tolerance of P. aeruginosa grown under urinary tract conditions decrease the efficiency of antibiotic treatment of UTIs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21984270     DOI: 10.1007/s00284-011-0026-y

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  52 in total

1.  Experimental reproducibility in flow-chamber biofilms.

Authors:  A Heydorn; B K Ersbøll; M Hentzer; M R Parsek; M Givskov; S Molin
Journal:  Microbiology       Date:  2000-10       Impact factor: 2.777

Review 2.  Mechanisms of antibiotic resistance in Pseudomonas aeruginosa.

Authors:  P A Lambert
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

Review 3.  The role of biofilm infection in urology.

Authors:  P Tenke; B Kovacs; M Jäckel; E Nagy
Journal:  World J Urol       Date:  2006-01-10       Impact factor: 4.226

Review 4.  Influence of growth rate on susceptibility to antimicrobial agents: biofilms, cell cycle, dormancy, and stringent response.

Authors:  P Gilbert; P J Collier; M R Brown
Journal:  Antimicrob Agents Chemother       Date:  1990-10       Impact factor: 5.191

5.  Mode of action of GR69153, a novel catechol-substituted cephalosporin, and its interaction with the tonB-dependent iron transport system.

Authors:  P Silley; J W Griffiths; D Monsey; A M Harris
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

6.  Membrane-bound nitrate reductase is required for anaerobic growth in cystic fibrosis sputum.

Authors:  Kelli L Palmer; Stacie A Brown; Marvin Whiteley
Journal:  J Bacteriol       Date:  2007-03-30       Impact factor: 3.490

Review 7.  Anaerobic metabolism and quorum sensing by Pseudomonas aeruginosa biofilms in chronically infected cystic fibrosis airways: rethinking antibiotic treatment strategies and drug targets.

Authors:  Daniel J Hassett; John Cuppoletti; Bruce Trapnell; Sergei V Lymar; John J Rowe; Sang Sun Yoon; George M Hilliard; Kislay Parvatiyar; Moneesha C Kamani; Daniel J Wozniak; Sung Hei Hwang; Timothy R McDermott; Urs A Ochsner
Journal:  Adv Drug Deliv Rev       Date:  2002-12-05       Impact factor: 15.470

Review 8.  Nitrite and nitrate analyses: a clinical biochemistry perspective.

Authors:  G Ellis; I Adatia; M Yazdanpanah; S K Makela
Journal:  Clin Biochem       Date:  1998-06       Impact factor: 3.281

Review 9.  The etiology of urinary tract infection: traditional and emerging pathogens.

Authors:  Allan Ronald
Journal:  Am J Med       Date:  2002-07-08       Impact factor: 4.965

10.  Dynamic interactions of biofilms of mucoid Pseudomonas aeruginosa with tobramycin and piperacillin.

Authors:  H Anwar; J L Strap; K Chen; J W Costerton
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

View more
  13 in total

1.  Evaluation of Aminoglycoside and Carbapenem Resistance in a Collection of Drug-Resistant Pseudomonas aeruginosa Clinical Isolates.

Authors:  Selina Y L Holbrook; Sylvie Garneau-Tsodikova
Journal:  Microb Drug Resist       Date:  2017-12-20       Impact factor: 3.431

Review 2.  The biofilm matrix: multitasking in a shared space.

Authors:  Hans-Curt Flemming; Eric D van Hullebusch; Thomas R Neu; Per H Nielsen; Thomas Seviour; Paul Stoodley; Jost Wingender; Stefan Wuertz
Journal:  Nat Rev Microbiol       Date:  2022-09-20       Impact factor: 78.297

Review 3.  Resistance Is Not Futile: The Role of Quorum Sensing Plasticity in Pseudomonas aeruginosa Infections and Its Link to Intrinsic Mechanisms of Antibiotic Resistance.

Authors:  Kayla A Simanek; Jon E Paczkowski
Journal:  Microorganisms       Date:  2022-06-18

4.  Antimicrobial susceptibility pattern of aerobic microbial isolates in a clinical laboratory in Karachi - Pakistan.

Authors:  Rubina Sabir; S Faraz Danish Alvi; Asher Fawwad
Journal:  Pak J Med Sci       Date:  2013-05       Impact factor: 1.088

5.  Genome Sequence of the Small-Colony Variant Pseudomonas aeruginosa MH27, Isolated from a Chronic Urethral Catheter Infection.

Authors:  Petra Tielen; Daniel Wibberg; Jochen Blom; Nathalie Rosin; Ann-Kathrin Meyer; Boyke Bunk; Max Schobert; Reinhilde Tüpker; Sarah Schatschneider; Christian Rückert; Andreas Albersmeier; Alexander Goesmann; Frank-Jörg Vorhölter; Dieter Jahn; Alfred Pühler
Journal:  Genome Announc       Date:  2014-01-23

6.  The alternative role of enterobactin as an oxidative stress protector allows Escherichia coli colony development.

Authors:  Conrado Adler; Natalia S Corbalan; Daiana R Peralta; María Fernanda Pomares; Ricardo E de Cristóbal; Paula A Vincent
Journal:  PLoS One       Date:  2014-01-02       Impact factor: 3.240

7.  Effects of azithromycin on Pseudomonas aeruginosa isolates from catheter-associated urinary tract infection.

Authors:  Zhi-Gang Xu; Yu Gao; Jian-Guo He; Wei-Feng Xu; Mei Jiang; Huan-Sheng Jin
Journal:  Exp Ther Med       Date:  2014-12-08       Impact factor: 2.447

8.  Efficacy of cinnamon bark oil and cinnamaldehyde on anti-multidrug resistant Pseudomonas aeruginosa and the synergistic effects in combination with other antimicrobial agents.

Authors:  Itsaraporn Utchariyakiat; Suvimol Surassmo; Montree Jaturanpinyo; Piyatip Khuntayaporn; Mullika Traidej Chomnawang
Journal:  BMC Complement Altern Med       Date:  2016-06-01       Impact factor: 3.659

9.  Genome Sequence of the Acute Urethral Catheter Isolate Pseudomonas aeruginosa MH38.

Authors:  Daniel Wibberg; Petra Tielen; Jochen Blom; Nathalie Rosin; Max Schobert; Reinhilde Tüpker; Sarah Schatschneider; Dominik Spilker; Andreas Albersmeier; Alexander Goesmann; Frank-Jörg Vorhölter; Alfred Pühler; Dieter Jahn
Journal:  Genome Announc       Date:  2014-03-13

10.  Genome Sequence of the Urethral Catheter Isolate Pseudomonas aeruginosa MH19.

Authors:  Frank-Jörg Vorhölter; Petra Tielen; Daniel Wibberg; Maike Narten; Max Schobert; Reinhilde Tüpker; Jochen Blom; Sarah Schatschneider; Anika Winkler; Andreas Albersmeier; Alexander Goesmann; Alfred Pühler; Dieter Jahn
Journal:  Genome Announc       Date:  2015-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.